Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect

[Image: see text] Artificial antigen-presenting cells (aAPCs) have recently gained a lot of attention. They efficiently activate T cells and serve as powerful replacements for dendritic cells in cancer immunotherapy. Focusing on a specific class of polymer-based aAPCs, so-called synthetic dendritic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammink, Roel, Mandal, Subhra, Eggermont, Loek J., Nooteboom, Marco, Willems, Peter H. G. M., Tel, Jurjen, Rowan, Alan E., Figdor, Carl G., Blank, Kerstin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377267/
https://www.ncbi.nlm.nih.gov/pubmed/28393131
http://dx.doi.org/10.1021/acsomega.6b00436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377267/
https://www.ncbi.nlm.nih.gov/pubmed/28393131
http://dx.doi.org/10.1021/acsomega.6b00436

Ejemplares similares